REFERENCES
CASES
We are a proven partner for success having prepared and facilitated high profile M&A and business development transactions, with many of them having been top ranked among the leading European and global deals.
In the following you will find a select list of deal references.
BENCHMARK - U3 PHARMA - DAIICHI SANKYO
The success of a business development process very much depends on the personal credibility, professional quality and scientific as well as commercia. excellence of our transaction partners. In this respect Irina and her team have been crucial to the completion of our acquisition of U3 Pharma.
DICK VAN DUYNE, SENIOR ADVISOR
(former Head of Global Business Development)
DAICHI SANKYO, CO. LTD
BENCHMARK - EUROPEAN BIOTECH FIRM - MITSUBISHI TANABE
Since we have known each other, Irina has been consistently impressive in her ability to build cases, design BD strategies and appropriately implement them. Among the European Biotech community she is one of the few BD consultants with a solid track record of significant achievements. As investors, we never hesitate to invite our portfolio companies to check her out.
GILLES NOBÉCOURT
PARTNER AT EDMOND DE ROTHSCHILD INVESTMENT PARTNERS
BENCHMARK - EUROPEAN BIOTECH FIRM - ALLERGAN
BENCHMARK - EUROPEAN BIOTECH COMPANY - MERCK & CO
DEVELOPMENT STRATEGY GUIDANCE
CLINICAL DEVELOPMENT & MARKET ACCESS STRATEGY
When working with Staatz, we were able to set up a trial design that would give us the necessary clinical and pharmaco-economic endpoints laying the foundation for a positive outcome in payer negotiations in the major European markets.
LAUNCH MANAGEMENT (HTA processes)
For our orphan disease product, the Staatz team consulted and supported us throughout value dossier development and country-specific negotiations. Not only did we obtain targeted reimbursement prices but also gained easily adaptable outputs for further use with our affiliates.
HEALTH TECHNOLOGY ASSESSMENT READINESS
Working with Staatz Business Development helped shape our processes for market access readiness: with clearly defined responsibilities, to-dos and solutions, we can now follow an approach that is streamlined for both global and affiliate teams.